Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immunovant (IMVT)
NASDAQ:IMVT
Immunovant (IMVT) Ownership - Who Owns Immunovant?
704 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 26, 2024 | Jay S Stout Cto | Sold | $209207 |
| Apr 26, 2024 | Sold | $94243 | |
| Apr 26, 2024 | Mark Levine Clo | Sold | $114531 |
| Apr 19, 2024 | Mark Levine Clo | Sold | $285554 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Bought | $94086 | |
| Mar 31, 2024 | Sold | $6160095 | |
| Mar 31, 2024 | Bought | $41663874 | |
| Mar 31, 2024 | Bought | $58454347 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,228,446 | Institution | 4.29% | 191,213,292 | |
| 5,192,055 | Institution | 3.57% | 159,396,089 | |
| 3,770,260 | Institution | 2.59% | 115,746,982 | |
| 2,963,212 | Institution | 2.04% | 90,970,608 | |
| 2,492,529 | Institution | 1.72% | 76,520,640 | |
| 2,384,552 | Institution | 1.64% | 73,205,746 | |
| 1,809,172 | Institution | 1.25% | 55,541,580 | |
| 1,428,000 | Institution | 0.98% | 43,839,600 | |
| 1,289,504 | Institution | 0.89% | 39,587,773 | |
| 822,543 | Institution | 0.57% | 25,252,070 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,192,055 | Institution | 3.57% | 159,396,089 | |
| 3,770,260 | Institution | 2.59% | 115,746,982 | |
| 1,428,000 | Institution | 0.98% | 43,839,600 | |
| 822,543 | Institution | 0.57% | 25,252,070 | |
| 780,367 | Institution | 0.54% | 23,957,267 | |
| 779,496 | Institution | 0.54% | 23,930,527 | |
| 629,335 | Institution | 0.43% | 19,320,585 | |
| 618,451 | Institution | 0.43% | 18,986,446 | |
| 615,000 | Institution | 0.42% | 18,880,500 | |
| 611,469 | Institution | 0.42% | 18,772,098 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,317,449 | Institution | 1.60% | 72,953,295 | |
| 2,106,805 | Institution | 1.45% | 57,810,729 | |
| 1,662,981 | Institution | 1.14% | 45,632,199 | |
| 1,275,092 | Institution | 0.88% | 40,139,896 | |
| 1,115,751 | Institution | 0.77% | 30,616,207 | |
| 842,520 | Institution | 0.58% | 23,118,749 | |
| 454,135 | Institution | 0.31% | 14,296,170 | |
| 431,599 | Institution | 0.30% | 13,586,737 | |
| 268,451 | Institution | 0.18% | 8,450,837 | |
| 203,075 | Institution | 0.14% | 5,572,378 |
FAQ
Who Owns Immunovant (IMVT)?
Currently, no data Available
What percentage of Immunovant (IMVT) stock is held by institutional investors?
Currently, no data Available
What percentage of Immunovant (IMVT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Immunovant (IMVT)?
Vanguard owns the most shares of Immunovant (IMVT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.